Aminoglutethimide for Metastatic Breast Cancer
Authors: ROBERT J. MISBIN
Journal: Annals of Internal Medicine (1977)

Comments1 June 1977Aminoglutethimide for Metastatic Breast CancerROBERT J. MISBIN, M.D.ROBERT J. MISBIN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-86-6-828 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In his recent review of hormonal therapy for metastatic breast cancer, Dr. Korenman (1) did not include a relatively new but promising alternative to surgical adrenalectomy, blockade of adrenocortical synthesis by aminoglutethimide. Santen, Lipton, and Kendall (2) have reported that eight of 22 patients (36%) with metastatic breast cancer had objective remission lasting from 3 to more than 19 months when treated with aminoglutethimide and glucocorticoid replacement. Three additional patients (14%) experienced a subjective relief of symptoms. In a series of 65 patients reported by Gale and associates (3), 21 (33%) had objective remission lasting from 3...References1. KORENMAN S: Hormonal factors in the treatment of metastatic breast cancer, pp. 68-70 Google Scholar HASKELL C in (moderator): Systemic Therapy for Metastatic Breast Cancer. Ann Intern Med 86:68-80, 1977 LinkGoogle Scholar2. SANTENLIPTONKENDALL RAJ: Successful medical adrenalectomy with aminoglutethimide. JAMA 230:1661-1665, 1974 CrossrefMedlineGoogle Scholar3. GALESHEEHEGOULD KPL: Treatment of advanced breast cancer with aminoglutethimide. An 8 year experience (abstract). Clin Res 24:376A, 1976 Google Scholar4. NEWSOMEBROWNTERZ HPJ: Plasma steroids and clinical response with medical adrenalectomy for advanced breast cancer (abstract). Clin Res 24:379A, 1976 Google Scholar5. Data submitted to Ciba-Geigy, from which a report was filed with the Food and Drug Administration in September 1975 Google Scholar6. MISBINCANARYWILLARD RJD: Aminoglutethimide in the treatment of Cushing's syndrome. J Clin Pharmacol 16:645-651, 1976 CrossrefMedlineGoogle Scholar1. HASKELLSPARKSGRAZEKORENMAN CFPS: Systemic therapy for metastatic breast cancer. Ann Intern Med 86:68-80, 1977 LinkGoogle Scholar2. LEGHACARTER SS: Antiestrogens in the treatment of breast cancer. Cancer Treat Rev 3:205-216, 1976 CrossrefMedlineGoogle Scholar3. ANSFIELDDAVISELLERBY FHR: A clinical trial of megestrol acetate in advanced breast cancer. Cancer 33:907-910, 1974 CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ROBERT J. MISBIN, M.D.Affiliations: Department of Medicine University of Florida School of Medicine Gainesville, FL 32610 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast CarcinomaRICHARD J. SANTEN, M.D., THOMAS J. WORGUL, M.D., ALLAN LIPTON, M.D., HAROLD HARVEY, M.D., ALICE BOUCHER, C.R.N.P., EUGENIUSZ SAMOJLIK, Ph.D., SAMUEL A. WELLS, M.D.CommentariesSuppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A reviewTreatment of metastatic breast cancer with aminoglutethimideCancer of the BreastHormone relationships in breast cancer: The role of receptor-binding proteins 1 June 1977Volume 86, Issue 6Page: 828-829KeywordsAdrenalectomyBreast cancerHormonal therapy ePublished: 1 December 2008 Issue Published: 1 June 1977 PDF downloadLoading ...